Takeda Pharmaceutical Co Ltd (TKPHF) stock
TKPHFOTCPharmaceutical PreparationsAlso trades as TAK
$39.00+0.36 (+0.93%)
Close on Oct 19, 2026Market cap $134.41BP/E –Yield –
Takeda Pharmaceutical cash
Cash and short-term investments held at the end of each period.
Takeda Pharmaceutical's cash was ¥595.05B at Mar 31, 2026. For fiscal 2026 it was ¥595.05B, up 54.5% from the year before. Over ten years it grew 2.8% a year on average. The highest annual figure on record is ¥966.22B in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | ¥595.05B | +54.5% |
| FY2025 | Mar 31, 2025 | ¥385.11B | -15.9% |
| FY2024 | Mar 31, 2024 | ¥457.80B | -14.2% |
| FY2023 | Mar 31, 2023 | ¥533.53B | -37.2% |
| FY2022 | Mar 31, 2022 | ¥849.70B | -12.1% |
| FY2021 | Mar 31, 2021 | ¥966.22B | +51.5% |
| FY2020 | Mar 31, 2020 | ¥637.61B | -9.2% |
| FY2019 | Mar 31, 2019 | ¥702.09B | +138.4% |
| FY2018 | Mar 31, 2018 | ¥294.52B | -7.8% |
| FY2017 | Mar 31, 2017 | ¥319.46B | -29.2% |
| FY2016 | Mar 31, 2016 | ¥451.43B | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026 | Mar 31, 2026 | ¥595.05B | -30.0% |
| Q4 FY2025 | Mar 31, 2025 | ¥385.11B | -60.1% |
| Q4 FY2024 | Mar 31, 2024 | ¥457.80B | -28.2% |
| Q4 FY2023 | Mar 31, 2023 | ¥533.53B | -24.0% |
| Q4 FY2022 | Mar 31, 2022 | ¥849.70B | +188.5% |
| Q4 FY2021 | Mar 31, 2021 | ¥966.22B | +202.5% |
| Q4 FY2020 | Mar 31, 2020 | ¥637.61B | +41.2% |
| Q4 FY2019 | Mar 31, 2019 | ¥702.09B | – |
| Q4 FY2018 | Mar 31, 2018 | ¥294.52B | – |
| Q4 FY2017 | Mar 31, 2017 | ¥319.46B | – |
| Q4 FY2016 | Mar 31, 2016 | ¥451.43B | – |